Keyphrases
Senescence
100%
Doxorubicin-induced Cardiotoxicity
100%
Doxorubicin
57%
Engineered Heart Tissue
57%
Senomorphics
57%
Clinically Significant
28%
Left Ventricle
28%
Carboxamide
28%
Senescence-associated
28%
Cardiotoxicity
28%
Resveratrol
28%
Ribonucleotides
28%
5-Aminoimidazoles
28%
In(III)
14%
Molecular Mechanism
14%
Pathophysiology
14%
Three-dimensional (3D)
14%
Cancer Treatment
14%
Potential Treatments
14%
Targeted Treatment
14%
Treatment Regimen
14%
Cellular Senescence
14%
Cardiomyocytes
14%
Force Generation
14%
Senescence Markers
14%
Pluripotent
14%
Functional Improvement
14%
Troponin Release
14%
Patient Treatment
14%
Dilatation
14%
Decreased Expression
14%
Drug Lead
14%
Improved Function
14%
Medicine and Dentistry
Cardiotoxicity
100%
Doxorubicin
100%
Engineered Heart Tissue
40%
Left Ventricle
20%
Resveratrol
20%
5 Amino 4 Imidazolecarboxamide
20%
Ribonucleotide
20%
In Vitro
10%
Pathophysiology
10%
Cancer Therapy
10%
Cardiac Muscle Cell
10%
Troponin
10%
Cellular Senescence
10%
Upregulation
10%
Biopsy Technique
10%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Cardiotoxicity
100%
Resveratrol
20%
Ribonucleotide
20%
5 Amino 4 Imidazolecarboxamide
20%
Malignant Neoplasm
10%
Pathophysiology
10%
Troponin
10%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
Ribonucleotide
20%
Resveratrol
20%
Cardiac Muscle Cell
10%
Troponin
10%
Upregulation
10%
Dilatation
10%